...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Sabizabulin - mCRPC- used now for Covid 19.

fouremm - "I dread the idea of an IPO because I think the single biggest influence on share price at the time will be millions shares looking to escape current management. "

I agree! Zenith can't handle an IPO without a major success event to drive the price. Otherwise, it will go the other way and financing will be even worse like RVX.

Share
New Message
Please login to post a reply